Skip to content
healthcare.dev

Renflexis

NDC 78206-162, infliximab, injection, powder, lyophilized, for solution, from Organon LLC.

Product NDC
78206-162
Status
Listed
Labeler
Organon LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761054
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/78206-162 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INFLIXIMAB100 mg/1

Pharmacologic classes

Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Package NDCNDC-11Package
78206-162-01782060162011 VIAL in 1 CARTON (78206-162-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (78206-162-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dbf738c4-3fac-4422-a9d8-51d9c83a8789
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=78206-162

Use it

Look up 78206-162 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/78206-162 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 78206-162. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.